Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Short Interest Update

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 48,700 shares, a decline of 16.6% from the December 15th total of 58,400 shares. Based on an average daily trading volume, of 900 shares, the short-interest ratio is presently 54.1 days.

Surgical Science Sweden AB (publ) Stock Performance

SUSRF remained flat at $14.50 on Thursday. Surgical Science Sweden AB has a 52-week low of $11.30 and a 52-week high of $14.53. The firm has a 50 day moving average of $13.07 and a 200-day moving average of $12.35.

Surgical Science Sweden AB (publ) Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.